Form 4: Research Frontiers Director Eyal Peso Acquires Stock Options

Director Eyal Peso of Research Frontiers Inc. was granted 45,000 stock options, some of which are contingent on shareholder approval.

Summary

• Eyal Peso, a director at Research Frontiers Inc., was granted 45,000 stock options on December 31, 2024.
• The options have an exercise price of $1.68 per share.
• 27,950 of these options are contingent on shareholder approval at the 2025 Annual Meeting of Stockholders for additional shares under the 2019 Equity Incentive Plan.
• If shareholder approval is not received, these contingent options will automatically terminate.
• Following this transaction, Mr. Peso beneficially owns 90,000 derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of stock options being granted to a director. It is a positive sign of alignment between management and shareholders, but not a major event.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting of a portion of the options is contingent on shareholder approval, which could encourage positive engagement with shareholders.

Risks

• The contingent options will terminate if shareholder approval is not obtained at the 2025 Annual Meeting.
• The value of the options is dependent on the future performance of the company's stock price.

Future Outlook

The vesting of 27,950 options is contingent on shareholder approval at the 2025 Annual Meeting of Stockholders.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard practice for incentivizing directors and executives across various industries.
• The specific terms of the grant, such as the exercise price and vesting conditions, are typical for such arrangements.
• The contingency on shareholder approval is a measure to ensure alignment with shareholder interests, which is a common practice.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign of alignment between management and shareholder interests.
• The contingent nature of some options may encourage shareholder engagement.

Next Steps

• Shareholder approval will be sought at the 2025 Annual Meeting for the contingent options.

Key Dates

Keywords

stock options, Research Frontiers Inc, Eyal Peso, director, equity incentive plan, shareholder approval, derivative securities